IX生物制藥
42C0.5302.75% ( -0.015 )
延遲 已收盤: 10月15日 17:16:00全部股東
股東類型
- 公眾及其他43.10%
- 個人與內幕人士36.51%
- 機構投資者17.46%
- 私人企業2.93%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Yip Hang LeeExecutive Chairman & CEO | 22.81% | 2.49 億 | 0.55% | +1,162.08 萬 | 15/07/2026 |
CGS International Securities Singapore Pte. Ltd. | 10.86% | 1.19 億 | 0.58% | +0 | 26/09/2025 |
Phuah Lee | 4.99% | 5,459.32 萬 | 0.75% | -680.00 萬 | |
Lion Global Investors Limited | 4.87% | 5,325.38 萬 | 2.77% | +3,083.33 萬 | 22/07/2026 |
Boon Lock Seah | 3.19% | 3,484.59 萬 | 0.17% | +0 | 26/09/2025 |
C2c Biopharma Holdings Pte. Ltd | 1.53% | 1,672.62 萬 | 0.08% | +0 | 26/09/2025 |
Hwee Hoon Chan | 1.41% | 1,541.30 萬 | 0.07% | +0 | 26/09/2025 |
Wetwaters 8 (S) Pte Ltd | 1.40% | 1,527.32 萬 | 0.07% | +0 | 26/09/2025 |
Shing Tung HoNon-Executive Non-Independent Director | 1.21% | 1,320.02 萬 | 0.07% | +100.40 萬 | 14/07/2026 |
Beng Sng | 1.03% | 1,130.00 萬 | 0.05% | +0 | 26/09/2025 |
Hardeep Kaur | 1.01% | 1,100.01 萬 | 0.05% | +0 | 26/09/2025 |
Futu Singapore Pte. Ltd. | 0.69% | 756.37 萬 | 0.04% | +0 | 26/09/2025 |
Jasvinpal Narulla | 0.66% | 722.46 萬 | 0.03% | +0 | 26/09/2025 |
Maybank Securities Pte. Ltd. | 0.63% | 689.57 萬 | 0.03% | +0 | 26/09/2025 |
Bank of Singapore Limited | 0.17% | 190.00 萬 | -- | +190.00 萬 | 22/07/2026 |
Patrick Donald DaviesNon-Executive Lead Independent Director | 0.10% | 111.06 萬 | <0.01% | +10.62 萬 | 13/05/2026 |
Woon Keng TeoIndependent Non-Executive Director | 0.10% | 104.79 萬 | <0.01% | +9.91 萬 | 13/05/2026 |
PHEIM Asset Management Sdn Bhd | 0.07% | 76.79 萬 | <0.01% | +0 | 31/12/2025 |
Dimensional Fund Advisors LP | 0.06% | 61.70 萬 | 0.43% | -459.22 萬 | 30/09/2026 |
BlackRock, Inc. | 0.06% | 60.89 萬 | <0.01% | +0 | 30/09/2026 |